| NDC Code | 19515-896-11 |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (19515-896-11) > 5 mL in 1 VIAL, MULTI-DOSE (19515-896-01) |
| Product NDC | 19515-896 |
| Product Type Name | VACCINE |
| Proprietary Name | Flulaval Quadrivalent |
| Proprietary Name Suffix | 2017/2018 |
| Non-Proprietary Name | Influenza Virus Vaccine |
| Dosage Form | SUSPENSION |
| Usage | INTRAMUSCULAR |
| Start Marketing Date | 20170707 |
| Marketing Category Name | BLA |
| Application Number | BLA125163 |
| Manufacturer | ID Biomedical Corporation of Quebec |
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
| Strength | 15; 15; 15; 15 |
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |